Table 3. In Vitro Metabolic Stability of 7aa.
| mouse hepatocytes | |
|---|---|
| in vitro t1/2 [min] | 160 |
| Clint [μL/106 cells/min] | 9.0 |
| Clint (pred. in vivo) [mL/min] | 2.1 |
| ClH (pred.) [mL/min] | 0.05 |
| Epred | 0.03 |
| mouse liver microsomes | |
|---|---|
| in vitro t1/2 [min] | 87 |
| Clint [μL/106 cells/min] | 16 |
| Clint (pred. in vivo) [mL/min] | 1.3 |
| ClH (pred.) [mL/min] | 0.03 |
| Epred | 0.01 |
| human liver microsomes | |
|---|---|
| in vitro t1/2 [min] | 103 |
| Clint [μL/106 cells/min] | 13 |
| Clint (pred. in vivo) [mL/min] | 630 |
| ClH (pred.) [mL/min] | 14 |
| Epred | 0.01 |
Abbreviations: t1/2, elimination half-life; Clint, intrinsic clearance; ClH, hepatic clearance; Epred, predicted hepatic extraction ratio (the fraction of drug removed from blood by the liver in one passage); and pred., predicted.